Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT02038816. IPD Sharing: NO. Countries: 1. Publications: 0.
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01311258. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01497145. IPD Sharing: Not stated. Countries: 2. Publications: 0.
CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03929211. IPD Sharing: NO. Countries: 1. Publications: 0.
S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00016419. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00039091. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00003681. IPD Sharing: Not stated. Countries: 7. Publications: 0.
A Safety and Efficacy Study of SHR-1702 Monotherapy in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT04443751. IPD Sharing: NO. Countries: 1. Publications: 0.
CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04493164. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01324960. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03393611. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Relevance of DNMT and HDAC Gene SNP on the Response to Decitabine Therapy for Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04515914. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of a Question Prompt List for Patients With Myelodysplastic Syndromes (QPL-MDS)
ClinicalTrials.gov study NCT02781441. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00003827. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
ClinicalTrials.gov study NCT00084916. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CBX-250 in Participants With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
ClinicalTrials.gov study NCT06994676. IPD Sharing: YES. Countries: 1. Publications: 0.
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic M
ClinicalTrials.gov study NCT04375631. IPD Sharing: NO. Countries: 1. Publications: 0.
Tipifarnib in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00005845. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03572764. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00050843. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.